z-logo
open-access-imgOpen Access
Reversal of Jaundice in Two Patients with Inoperable Cholangiocarcinoma Treated with Cisplatin and Gemcitabine Combination
Author(s) -
Maarten Criel,
F. Geurs,
S. Ponette,
Katrien Bulte,
J. Ponette
Publication year - 2012
Publication title -
case reports in hepatology
Language(s) - English
Resource type - Journals
eISSN - 2090-6587
pISSN - 2090-6595
DOI - 10.1155/2012/138381
Subject(s) - gemcitabine , jaundice , medicine , tolerability , cisplatin , chemotherapy , bilirubin , oncology , obstructive jaundice , liver function , combination chemotherapy , gastroenterology , adverse effect
Two patients are presented with severe jaundice, due to inoperable cholangiocarcinoma. The chemotherapeutic approach in patients with severe jaundice is discussed. Many schedules of chemotherapy were developed in this tumor type with normal serum bilirubin. We report here the first successful use of cisplatin and gemcitabine combination chemotherapy in these patients. Tolerability was good and liver function tests gradually improved.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom